Acurx Pharmaceuticals, Inc. (ACXP) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Acurx Pharmaceuticals, Inc. (ACXP) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.1M, listed on NASDAQ, employing roughly 4 people, carrying a beta of -2.09 to the broader market. Acurx Pharmaceuticals, Inc. Led by David Luci, public since 2021-06-25.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for ACXP as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →